Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
about
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsAdjuvants for peptide-based cancer vaccinesComparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responsesAcute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses.Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironmentAntigen capture and archiving by lymphatic endothelial cells following vaccination or viral infectionAgonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection.IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathwayLung dendritic cells at the innate-adaptive immune interface.IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses.Type I IFN-dependent T cell activation is mediated by IFN-dependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression.An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates.T cell vaccinology: exploring the known unknowns.T Cell Vaccinology: Beyond the Reflection of Infectious ResponsesCo-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cellsPhenotype and function of protective, CD4-independent CD8 T cell memory.Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.Towards personalized, tumour-specific, therapeutic vaccines for cancer.IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells.
P2860
Q27012618-B58D59FF-4F32-4C1B-8DA3-245C205DB848Q28072236-310119AC-0682-4AC8-A4CB-45A11F0EA446Q28507643-95D4659C-C493-41A3-80A1-1597D45A86E3Q30275560-172B9791-9D83-4D0A-8774-4E061B5C3753Q30278537-B8C3CD31-9ECF-4EA6-B86C-5ABAF6642515Q33718737-B6C4D8FA-DF51-46BC-AE4C-1D2D7BC0E5B5Q33815647-8487F8F6-036C-45F8-AED2-CB51446052BEQ34105274-17E6B6FA-2DCD-4CEE-A065-145C55D1CBB6Q34581324-0B4225E2-8C51-4643-8E8A-223FD72328E5Q35220395-04B2B09E-2EC4-471A-8498-57A32CD61892Q35505246-476A30C4-D513-4D9A-8085-09EEF5A4F531Q35621594-38856E5D-F86D-4496-B345-C3B707523CA3Q35658873-F668F86F-6AA4-497F-B7A1-974CE7E35C37Q35717963-85509FD6-69E1-4D9B-9093-1A4749B53865Q35864569-E187BE69-7856-448D-B872-2866EBA5AB84Q36487216-2BB909D0-FE21-4777-ADF2-C5156DE610E2Q36642440-2194AFEF-DB97-4DEA-A161-EA014145A6C5Q37083610-8DD3822F-A91D-4CD0-83B3-DEA9ED0C6A2EQ37579582-30B614B6-6D73-4FDE-B756-4FE3525A92ADQ38786054-36B5C930-43D9-41D0-A574-D7F132B48B2DQ45064262-3A61EBFB-4132-441E-92B0-B27461C0D246Q47789519-96F03E14-F642-434A-B343-65E8A1B466E7Q54615870-7902DDA6-7FAD-48BB-BB8C-A9DAC23894E0
P2860
Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Multiple innate signaling path ...... 70-dependent cellular immunity
@ast
Multiple innate signaling path ...... 70-dependent cellular immunity
@en
type
label
Multiple innate signaling path ...... 70-dependent cellular immunity
@ast
Multiple innate signaling path ...... 70-dependent cellular immunity
@en
prefLabel
Multiple innate signaling path ...... 70-dependent cellular immunity
@ast
Multiple innate signaling path ...... 70-dependent cellular immunity
@en
P2093
P2860
P1433
P1476
Multiple innate signaling path ...... 70-dependent cellular immunity
@en
P2093
Catherine Haluszczak
Jennifer A McWilliams
Phillip J Sanchez
Ross M Kedl
P2860
P304
P356
10.1016/J.VACCINE.2009.11.071
P407
P577
2009-12-06T00:00:00Z